Is West Pharmaceutical Services, Inc. (WST) A Good Stock To Buy Now?

What: West Pharmaceutical Services, Inc. (WST) has reported a 12% increase in revenue for the fiscal year 2025, reaching $**2.53 billion**.
Why: The company's growth is driven by its strong presence in the injectable solutions market, with a 15% increase in demand for its syringe systems.
Signal: WST's stock price has shown a 10% increase in the past quarter, indicating a positive market sentiment towards the company.
Target: Analysts have set a price target of $**230** for WST's stock, suggesting a potential 15% upside from its current price.
Risk: The company's reliance on the pharmaceutical industry makes it vulnerable to fluctuations in the market, with a potential 8% decline in revenue if demand for injectable solutions decreases.